Cellular senescence: Neither irreversible nor reversible
Journal of Experimental Medicine · 01.04.2024 · 221 (4)
DOI: 10.1084/jem.20232136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 22.02.2024. Verfasst von Maurice Reimann und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Department of Hematology, Oncology and Tumor Immunology, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Be…. Hauptthemen laut MEDLINE: Cellular Senescence, Aging. Die Arbeit wurde bisher 126-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Krebshilfe, Deutsche Forschungsgemeinschaft, Förderverein Hämatologie und Internistische Onkologie (Tyle Private Foundation).
Abstract (Originalsprache)
Cellular senescence is a critical stress response program implicated in embryonic development, wound healing, aging, and immunity, and it backs up apoptosis as an ultimate cell-cycle exit mechanism. In analogy to replicative exhaustion of telomere-eroded cells, premature types of senescence—referring to oncogene-, therapy-, or virus-induced senescence—are widely considered irreversible growth arrest states as well. We discuss here that entry into full-featured senescence is not necessarily a permanent endpoint, but dependent on essential maintenance components, potentially transient. Unlike a binary state switch, we view senescence with its extensive epigenomic reorganization, profound cytomorphological remodeling, and distinctive metabolic rewiring rather as a journey toward a full-featured arrest condition of variable strength and depth. Senescence-underlying maintenance-essential molecular mechanisms may allow cell-cycle reentry if not continuously provided. Importantly, senescent cells that resumed proliferation fundamentally differ from those that never entered senescence, and hence would not reflect a reversion but a dynamic progression to a post-senescent state that comes with distinct functional and clinically relevant ramifications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Medical Department of Hematology, Oncology and Tumor Immunology, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, and Molekulares Krebsforschungszentrum-MKFZ,…
- Johannes Kepler University , Linz, Austria.
- Department of Hematology and Oncology, Kepler University Hospital, Linz, Austria.
- Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association , Berlin, Germany.
ORCID-Profile: Maurice Reimann, Soyoung Lee, Clemens A Schmitt
Förderung
- Deutsche Krebshilfe
- Deutsche Forschungsgemeinschaft
- Förderverein Hämatologie und Internistische Onkologie (Tyle Private Foundation)
- German BMBF e:Med
Zitieren
APA
Reimann, M., Lee, S., & Schmitt, C. A. (2024). Cellular senescence: Neither irreversible nor reversible. Journal of Experimental Medicine, 221(4). https://doi.org/10.1084/jem.20232136
Vancouver
Reimann M, Lee S, Schmitt CA. Cellular senescence: Neither irreversible nor reversible. Journal of Experimental Medicine. 2024;221(4). doi:10.1084/jem.20232136
BibTeX
@article{Reimann2024,
author = {Reimann, Maurice and Lee, Soyoung and Schmitt, Clemens A},
title = {Cellular senescence: Neither irreversible nor reversible},
journal = {Journal of Experimental Medicine},
year = {2024},
volume = {221},
number = {4},
doi = {10.1084/jem.20232136}
}
EUVIMED